Evidence map›Paper›PMID 32753681›Full record

ReviewNature communications2020

Homogeneous and heterogeneous catalytic reduction of amides and related compounds using molecular hydrogen.

Jose R Cabrero-Antonino, Rosa Adam, Veronica Papa, Matthias Beller

Open access · goldAbstract readReview
In one paragraph

Review in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 218 citations in OpenAlex.

  1. Article
  2. Article
  3. Acid-base bifunctional porous liquids.Nature communications · 2026
    Article
  4. Article
  5. Article
  6. Selective Hydrogenation of Formamide to Methanol Over Supported Platinum Catalysts.Angewandte Chemie (International ed. in English) · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Recent advances in the cleavage of non-activated amides.Beilstein journal of organic chemistry · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Jose R Cabrero-AntoninoInstituto de Tecnología Química. Universitat Politècnica de València - Consejo Superior Investigaciones Científicas (UPV-CSIC). Avda. de los Naranjos s/n, València, 46022, Spain.ORCID http://orcid.org/0000-0001-9628-9803
Rosa AdamInstituto de Tecnología Química. Universitat Politècnica de València - Consejo Superior Investigaciones Científicas (UPV-CSIC). Avda. de los Naranjos s/n, València, 46022, Spain. roador1@itq.upv.es.ORCID http://orcid.org/0000-0001-9392-7187
Veronica PapaLeibniz-Institut für Katalyse, Albert-Einstein-Strasse 29a, Rostock, 18059, Germany.ORCID http://orcid.org/0000-0001-8107-7162
Matthias BellerLeibniz-Institut für Katalyse, Albert-Einstein-Strasse 29a, Rostock, 18059, Germany. matthias.beller@catalysis.de.ORCID http://orcid.org/0000-0001-5709-0965
Instituto de Tecnología Química · ESLeibniz Institute for Catalysis · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Catalytic hydrogenation of amides is of great interest for chemists working in organic synthesis, as the resulting amines are widely featured in natural products, drugs, agrochemicals, dyes, etc. Compared to traditional reduction of amides using (over)stoichiometric reductants, the direct hydrogenation of amides using molecular hydrogen represents a greener approach. Furthermore, amide hydrogenation is a highly versatile transformation, since not only higher amines (obtained by C-O cleavage), but also lower amines and alcohols, or amino alcohols (obtained by C-N cleavage) can be selectively accessed by fine tuning of reaction conditions. This review describes the most recent advances in the area of amide hydrogenation using H

Identifiers

PMID32753681
PMCPMC7403344
OpenAlexW3047515225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.